Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
83.59
+0.27 (0.32%)
Nov 20, 2024, 4:00 PM EST - Market closed
Globus Medical Market Cap
Globus Medical has a market cap or net worth of $11.38 billion as of November 21, 2024. Its market cap has increased by 143.61% in one year.
Market Cap
11.38B
Enterprise Value
11.21B
1-Year Change
143.61%
Ranking
Category
Stock Price
$83.59
Market Cap Chart
Since August 3, 2012, Globus Medical's market cap has increased from $1.22B to $11.38B, an increase of 832.82%. That is a compound annual growth rate of 19.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 11.35B | 54.51% |
| Dec 29, 2023 | 7.34B | -0.98% |
| Dec 30, 2022 | 7.42B | 1.22% |
| Dec 31, 2021 | 7.33B | 13.84% |
| Dec 31, 2020 | 6.44B | 9.95% |
| Dec 31, 2019 | 5.85B | 37.32% |
| Dec 31, 2018 | 4.26B | 7.60% |
| Dec 29, 2017 | 3.96B | 66.61% |
| Dec 30, 2016 | 2.38B | -10.27% |
| Dec 31, 2015 | 2.65B | 17.98% |
| Dec 31, 2014 | 2.25B | 19.34% |
| Dec 31, 2013 | 1.88B | 96.83% |
| Dec 31, 2012 | 956.00M | -21.65% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 11.98B |
| Neurocrine Biosciences | 11.89B |
| BioMarin Pharmaceutical | 11.71B |
| Solventum | 11.57B |
| AptarGroup | 11.13B |
| Smith & Nephew | 10.81B |
| Vaxcyte | 10.71B |
| Catalent | 10.65B |